Skip to main content

Table 1 Baseline characteristics of the study subjects

From: Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis

Characteristic

Healthy (Group A)

NAFLD (Group B)

AFLD (Group C)

P

Scheffe test

Total number of subjects

572 (62.7)

295 (32.3)

46 (5.0)

ND

ND

Age (years)

52.5 ± 10.4

52.7 ± 9.7

47.4 ± 9.1

0.003

b < a, c

Sex

 Male

298 (52.1)

210 (71.2)

39 (84.8)

  

 female

274 (47.9)

85 (28.8)

7 (15.2)

< 0.0001

 

 BMI (kg/m2)

23.8 ± 2.8

25.9 ± 3.5

33.5 ± 47.0

< 0.0001

a, b < c

 AST (IU/L)

30.3 ± 21.7

37.0 ± 37.6

36.6 ± 14.6

0.002

a < b

 ALT (IU/L)

26.9 ± 23.8

38.9 ± 29.5

39.2 ± 24.9

< 0.0001

a < b, c

ϓ-GT (IU/L)

35.1 ± 44.7

68.1 ± 219.5

75.2 ± 57.7

0.001

a < b

 Waist circumference (cm)

81.7 ± 9.1

87.8 ± 9.9

89.7 ± 9.5

< 0.0001

a < b, c

Smoking status

 None

436 (76.2)

209 (70.8)

14 (30.4)

< 0.0001

 

 Ex-smoker

3 (0.5)

1 (0.3)

0 (0.0)

< 0.0001

0.040

b < a < c

 Smoker

133 (23.3)

85 (28.8)

32 (69.6)

Exercise (frequency/week)

1.0 ± 1.8

0.8 ± 1.6

1.5 ± 2.0

Fatty liver grade

 Mild

ND

144 (48.8)

22 (47.8)

< 0.0001

 

 Moderate

ND

100 (33.9)

15 (32.6)

< 0.0001

 

 Severe

ND

51 (17.3)

9 (19.6)

  1. Data are presented as number (%) or mean ± standard deviation
  2. Abbreviations: NAFLD non-alcoholic fatty liver disease, AFLD alcoholic fatty liver disease, BMI body mass index, AST aspartate aminotransferase, ALT alanine aminotransferase, ϓ-GT gamma-glutamyl transferase, ND not done, NA not available
  3. aContinuous variables were analyzed using one-way analysis of variance, and the post hoc test was performed using the Scheffe test. Categorical variables were analyzed using the chi-square test